Here are five key notes:
1. Jennison Associates acquired 4,854 shares, now owning more than 1.07 million shares.
2. Jennison Associates now owns around 0.26 percent of HCA’s shares, worth around $83 million.
3. HCA traded down mid-day last week. The company has a 50-day moving average price of $67.73, with a 52-week low of $43.91.
4. HCA’s third quarter revenue was $9.86 billion, slightly down from the $9.9 billion consensus rating. The revenue was up 6.9 percent over the same period last year.
5. Recently Mizuho upped HCA’s price target from $86 to $103 and gave the stock a “buy” rating. Earlier in the year, JPMorgan Chase gave the company a “neutral” rating and $98 price objective.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
